Cupid Limited Increases Stake in GII Healthcare Investment through $5 Mn Follow-on Investment

Cupid Limited Increases Stake in GII Healthcare Investment through $5 Mn Follow-on Investment​

Mumbai, July 29, 2026 -Cupid Limited has announced an additional follow-on investment in GII Healthcare Investment Limited, a healthcare-focused investment platform managed by GII. This investment, amounting to USD 5 million and funded entirely through internal accruals, signals Cupid's sustained confidence in the long-term strategic value of GII's healthcare investment strategy.

The additional commitment follows an earlier investment by Cupid and reinforces the company’s belief in the future of the GCC healthcare sector. Cupid views the region as a market offering compelling long-term growth opportunities, driven by increasing healthcare expenditure, expanding populations, rising insurance penetration, and sustained government investment. The follow-on was executed at an attractive valuation, allowing the company to increase its participation in the platform's growth trajectory.

GII operates as a leading investment firm with assets under management exceeding USD 3.5 billion, maintaining a presence across Saudi Arabia, the UAE, Europe, the USA, and India. The platform holds a significant equity stake in prominent healthcare providers in Saudi Arabia, including Abeer Medical Company, a leading integrated healthcare provider, and AlMeswak Dental Company, a dental and derma care chain operating in the Kingdom.

Aditya Kumar Halwasiya, Chairman & Managing Director of Cupid Limited, commented on the development, stating that the decision to invest further demonstrates their strong conviction in GII's strategy. He added that this partnership reinforces confidence in the underlying healthcare assets and the long-term value creation potential of the platform, noting that the strategic relationship extends beyond financial returns as Cupid expands its global footprint.

Company Profile: Cupid Limited​

Cupid Limited, established in 1993, is an Indian manufacturer specializing in essential healthcare and hygiene products. Its core portfolio includes male and female barrier contraceptives, water-based personal care gels, and In-Vitro Diagnostic (IVD) kits. The company upholds a commitment to public health, maintaining ethical business practices aligned with international standards.

In alignment with its growth plans, Cupid has expanded its product range into Fast-Moving Consumer Goods (FMCG). This expansion includes fragrance products such as Eau De Parfums and Deodorants, personal care items like Toilet Sanitizers, Hair & Body Oils, and Face Wash, alongside other wellness solutions.

Cupid maintains a substantial presence in international markets, exporting products to over 125 countries. The company is the first globally to attain WHO/UNFPA pre-qualification for both male and female barrier contraceptives and holds a long-term agreement with WHO/UNFPA.

Operational Expansion Details​

To support its strategic growth, Cupid has made significant operational enhancements:

CUPID Stock Price Movement​

Today, Cupid Limited shares edged higher, settling at ₹233.77 after closing the trading session. The stock traded in a narrow range, hitting an intraday high of ₹234.25—near its annual peak—while over 35 million shares were transacted throughout the day.